Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Elevated Lp(a) and Established Atherosclerotic Cardiovascular Disease”

3 trials

Showing 3 of 3 results

Large-scale testing (Phase 3)Looking for participantsNCT06875973
What this trial is testing

Pelacarsen Roll-over Extension Program

Who this might be right for
Atherosclerotic Cardiovascular Disease
Novartis Pharmaceuticals 600
Large-scale testing (Phase 3)Active Not RecruitingNCT06267560
What this trial is testing

Lp(a) Lowering Study of Pelacarsen (TQJ230) in US Black/African American and Hispanic Participants With Elevated Lp(a) and Established ASCVD

Who this might be right for
Elevated Lp(a) and Established Atherosclerotic Cardiovascular Disease
Novartis Pharmaceuticals 422
Large-scale testing (Phase 3)Looking for participantsNCT06813911
What this trial is testing

Lp(a) Lowering Study of Pelacarsen (TQJ230) With Background Inclisiran in Participants With Elevated Lp(a) and Established ASCVD

Who this might be right for
Atherosclerotic Cardiovascular Disease (ASCVD)
Novartis Pharmaceuticals 340

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation